The Effect of Preparatory Education on Parental Stress and Attitudes in Parents of Children Entering Early Adolescence
NCT ID: NCT06568068
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-05-20
2025-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Healthy Lifestyle Behaviors in High School Students
NCT07244796
Effect of a Psychoeducational-Developmental Support Program on Adolescents' Relative Deprivation, Distress Levels, Peer Relations and Basic Psychological Needs
NCT07291349
The Effect of Transition to Adulthood Education Program on Family Quality of Life and Perceived Stress Level
NCT05587647
Adolescents' Health Literacy, Physical Activity and Healthy Eating Self-efficacy Levels
NCT06804031
Investigation of the Effects of Parent-Supported Psychosocial Development Program on 1-3 Year-Old Children
NCT06951165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EDUCATION GROUP
Procedures to be implemented in the Intervention Group:
The intervention group that will receive training determined after randomization; In Stage 1 An introductory meeting will be held, ERGEP will be announced and educational materials will be distributed. Pretest applications will be done. In Stage 2 A week consisting of four weeks and eight sessions on the following topics determined within the scope of ERGEP Trainings planned to be held in two sessions will be given once.
Educational Topics:
1. Developmental periods (oral, anal,a phallic, latent, genital)
2. Physical, psychological and social changes experienced in girls and boys during adolescence
3. Being an adolescent parent and healthy communication
4. Risky behaviors in life and sexual matters during adolescence In Stage 3 At the end of the training, measurement tools will be applied again. In Stage 4 Measuring tools will be repeated after 21 days.
training
The intervention group that will receive training determined after randomization; In Stage 1 An introductory meeting will be held, ERGEP will be announced and educational materials will be distributed. Pretest applications will be done. In Stage 2 A week consisting of four weeks and eight sessions on the following topics determined within the scope of ERGEP Trainings planned to be held in two sessions will be given once.
1. Developmental periods (oral, anal, phallic, latent, genital)
2. Physical, psychological and social changes experienced in girls and boys during adolescence
3. Being an adolescent parent and healthy communication
4. Risky behaviors in life and sexual matters during adolescence In Stage 3 At the end of the training, measurement tools will be applied again. In Stage 4 Measuring tools will be repeated after 21 days
CONTROL GROUP
Procedures to be applied in the Control Group:
In this group, where no intervention was made, the pretest, interim follow-up and posttest were the same as the intervention group.
It will be implemented in weeks. It was aimed to present the program to the control group parents at the end of the study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
training
The intervention group that will receive training determined after randomization; In Stage 1 An introductory meeting will be held, ERGEP will be announced and educational materials will be distributed. Pretest applications will be done. In Stage 2 A week consisting of four weeks and eight sessions on the following topics determined within the scope of ERGEP Trainings planned to be held in two sessions will be given once.
1. Developmental periods (oral, anal, phallic, latent, genital)
2. Physical, psychological and social changes experienced in girls and boys during adolescence
3. Being an adolescent parent and healthy communication
4. Risky behaviors in life and sexual matters during adolescence In Stage 3 At the end of the training, measurement tools will be applied again. In Stage 4 Measuring tools will be repeated after 21 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being a parent (mother or father) of a 4, 5, 6 and 7th grade student
* Ability to read and write
* Participation is voluntary
Exclusion Criteria
* Those who did not complete the pre-test, post-test and follow-up measurements
* Those who did not volunteer to participate in the study
25 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erzurum Technical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe Metin
Assist. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ayşe Metin
Erzurum, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.